Newsroom
Sorted by: Latest
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- fFORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name...
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Press Release on the Filing of AFD’s 2025 Universal Registration Document
PARIS--(BUSINESS WIRE)--Regulatory News: AFD (Agence Française de Développement) announced that it filed its 2025 Universal Registration Document containing the annual financial report with the French Financial Markets Authority (AMF) on 24 April 2026, under the number D.26-0290. The document is available free of charge to the public under the conditions laid down by current regulations and can be downloaded from the Investors section of the AFD website under the heading “Financial reports” (ht...
-
Prodalim Announced its Q1’2026 Results Presenting Accelerated Growth in the Specialty Ingredients & Solutions Activity
ROTTERDAM, Netherlands--(BUSINESS WIRE)--Tsahi Barak, Chairman of the Board and CEO of the Company, stated: “We are pleased to report a strong quarter during which we continued to successfully implement the company’s business strategy, which emphasizes, among other things, significant and profitable growth in the Specialty Ingredients & Solutions activity and the expansion of Solos’ infrastructure, our dealcoholization division. We believe that the positive momentum in this activity will co...
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Paceline Equity Partners Agrees to Sell R.E.L.A.M.
DALLAS--(BUSINESS WIRE)--Affiliates of Paceline Equity Partners, LLC ("Paceline"), a Dallas-based private equity manager, today announced that they have agreed to sell R.E.L.A.M., Inc. ("R.E.L.A.M." or the "Company"), a leading North American lessor of maintenance-of-way (“MOW”) and hi-rail equipment. Financial terms were not disclosed. Since Paceline's acquisition of R.E.L.A.M. – which was completed in conjunction with the acquisition of 1435 Rail to collectively form R.E.L.A.M – the Company u...
-
OMF Car Craft Redefines an Icon with the Launch of the Full Carbon Fiber Classic Bronco; Code Named #ClassicRaptor
HOUSTON--(BUSINESS WIRE)--OMF Car Craft, a leader in high-performance automotive design and bespoke builds, is proud to announce the official production of its newest masterpiece: the Carbon Fiber Classic Bronco. By fusing the timeless silhouette of the first-generation Ford Bronco with cutting-edge aerospace materials, OMF Car Craft has created a vehicle that offers legendary off-road capability with modern supercar performance. The OMF Carbon Fiber Bronco features a proprietary 100% carbon fi...
-
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced that its CARE Program (Comprehensive, Assessment, Risk, and Education) has been awarded “Best Overall Health Informatics Solution” in the 10th Annual MedTech Breakthrough Awards. The global program recognizes excellence in digital health and medical technology, selecting CARE from more than 5,000 nominations worldwide. The CA...
-
Dole plc Reports First Quarter 2026 Financial Results
DUBLIN--(BUSINESS WIRE)--Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three months ended March 31, 2026. First Quarter Highlights: Solid start to the year: 11.6% revenue growth reflecting positive momentum across the Group Robust consumer demand across our key markets, supported by evolving dietary preferences, GLP-1 adoption, and broader health and wellness trends Strong performance in Diversified Fresh Produce - Americas & ROW...
-
indie to Acquire CMOS Image Sensor Product Line from ams OSRAM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--indie Semiconductor (Nasdaq: INDI), an automotive solutions innovator, has announced the signing of a definitive agreement to acquire the fabless CMOS image sensor group from ams OSRAM AG for a total consideration of 40 million euros. With primary operations in Belgium and Portugal, this product line includes intelligent, high‑performance CMOS image sensors for a broad range of industrial, automation, and physical artificial intelligence (AI) applications....